Equities

IFR US ECM Calendar

 |  Robert Sherwood


Calendar

October 27: MapLight Therapeutics (US, biotech) – $250.8m IPO. 14.8m shares (Primary) at $17.00 fixed price. MS, JEFF, LEER, STFL. Nasdaq "MPLT". Pricing date based on automatic effectiveness 20 days from 10/6 S-1/A filing. T. Rowe Price indicated for $40m of offering. Goldman Sachs affiliate investing $8.1m through a concurrent private placement.

October 30: Navan (US, software) – $960m IPO. 36.9m shares (Primary, Secondary) at $24-$26. GS, CITI. Nasdaq “NAVN”. Pricing date based on automatic effectiveness 20 days from 10/6 S-1/A filing. Selling shareholders led by co-founders Ariel Cohen and Ilan Twig.   

New filings

Oct/Nov: Central Bancompany (US, banking) ─ $100m Nasdaq IPO. Terms TBD (Primary). MS, KBW. Nasdaq “CBC”. Uplisting from OTC market. DSP TBD.

Oct/Nov: Public Policy Holding (US, public affairs) ─ $50m Nasdaq IPO. Terms TBD (Primary, Secondary). OPCO, CGEN. Nasdaq “PPHC”. Cross-listing of common shares trading on LSE AIM market under the symbol “PPHC” at £10.75 ($14.30).

Topics
Equity Capital Initial Public Offerings (IPO) ABBs and Block Trades Americas Structured Equity North America Marketed Follow-Ons US Dollar United States
Issuers
MapLight Therapeutics Inc Central Bancompany Inc (CBCY.PK) Navan Inc Public Policy Holding Company Inc (PPHC.L)